Status:
COMPLETED
AQUA: Anticholinergic Side Effects QUestionnAire
Lead Sponsor:
Pierre and Marie Curie University
Conditions:
Overactive Bladder
Eligibility:
All Genders
18-100 years
Brief Summary
Overactive bladder syndrome (OAB) is very frequent and increase with age. Antimuscarinics allows improvement for OAB symptoms, quality of life and urodynamic parameters. However, antimuscarinics adher...
Detailed Description
Lower Urinary tract symptoms (LUTS) are widespread in the general population and their prevalence is expected to increase in the coming years as the elderly population increases. Indeed, overactive bl...
Eligibility Criteria
Inclusion
- OAB symptoms according to ICS definition
- neurogenic bladder
- antimuscarinic treatment
Exclusion
- Treatment change between first evaluation and second evaluation (Test retest validity)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04791111
Start Date
January 1 2020
End Date
August 31 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
department of Neuro-Urology, Hôpital Tenon
Paris, France, 70020